New scaffold aims to speed up wound healing
NCT ID NCT07347106
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding a collagen scaffold called Miro3D to standard wound care helps acute and chronic wounds heal better than standard care alone. About 70 adults with soft tissue wounds or pressure ulcers will be randomly assigned to one of two groups. The main goal is to see how much the wound shrinks over four weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Miro3D wound matrix (a collagen tissue scaffold)
- What this could lead to
- If it works, this could provide a new option to help stubborn wounds heal faster and reduce complications.
- What could go wrong
- This is a small, early-stage trial with only 70 participants, so results may not apply to everyone. The scaffold might not improve healing over standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PRESSURE ULCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden burden: could depression be common in chronic wound patients?
- Could a simple exercise program speed healing of diabetic foot ulcers?
- Can surgery go green? study measures carbon footprint of common orthopedic operations
- Glow-in-the-Dark wound camera study fizzles out
- New bandage for IVs could slash infection risk
- Cold plasma could heal stubborn wounds faster